Skip to main content
MZTI logo

MZTI · Marzetti Co

Track MZTI — free
Market Cap
$2.73B
Shares
27.29M

Price & Indicators

Drag to pan · scroll to zoom
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$99.92 Open$100.66 Day$99.41–102.23 52W close$99.92–181.12 Avg vol 30d424K Short int2.3M · 8.4% float · 5.9d Short vol54% Last earningsAug 25, 2026 DataJan 2020–Sep 2026 Filing10-K · Aug 25

Up next

Next earnings call
Nov 24, 2026 Est · unconfirmed · in 9 wks
filed Aug 25, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$1.93B
Trailing 12 months
Net income (TTM)
$191.61M
Trailing 12 months
Revenue growth YoY
-2.2%
Year over year
Operating margin
12.4%
Trailing 12 months
P / E (TTM)
14.3
Trailing earnings · reciprocal yield 7.0%
FCF yield
7.6%
TTM · current market cap
Return on invested capital
15.4%
Trailing 12 months
Net cash
−$174.18M
Latest balance sheet
Dividend yield
Trailing 12 months
Shares change YoY
-0.4%
Year over year · fewer shares
Price change (1Y)
-44.8%
Trailing year
Short interest
8.4%
Latest settlement · 5.9 days to cover
View all 115 metrics

AI Brief

Q4 FY26 earnings call · Aug 25, 2026
Q4 FY26

TL;DR. Marzetti reported record FY26 net sales, gross profit, and operating income while delivering a 12th straight quarter of gross margin expansion, but provided fiscal 2027 guidance for ~100 bps gross margin growth, mid-single-digit revenue growth, and a ~15% Q1 operating income decline due to a Cyclospora outbreak headwind.

Bullish
  • + Delivered record FY26 net sales, gross profit, and operating income with a 12th consecutive quarter of gross margin expansion
  • + Q4 gross margin expanded 220 bps to a record 24.5% and adjusted operating income grew 17.5%
  • + Raised the quarterly dividend for the 63rd consecutive year and repurchased $36.3 million of stock
  • + Generated record FY26 operating cash flow of $283.8 million, up $22.3 million
  • + Guided fiscal 2027 to ~100 bps gross margin expansion with mid-single-digit top-line growth, supported by Bachan's accretion
Bearish
  • Q4 reported consolidated net sales declined 2.2% to $465.0 million, with retail organic volumes down on pipeline comparisons
  • Cyclospora outbreak is expected to create an approximately 250 bps net sales headwind in fiscal Q1 2027
  • Q4 SG&A increased $12.3 million driven by Bachan's acquisition-related costs and incremental intangible amortization
  • Anticipated moderate input cost inflation of roughly 5% in fiscal 2027 creates a ~50 bps gross margin dilutive impact
  • Incurred ~$200 million in long-term debt to fund the Bachan's acquisition, introducing interest expense

AI-generated from the earnings call and 8-K · may contain errors · not investment advice

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Strong Sell Momentum Very Weak Sentiment Bearish Fundamentals Strong Quant / Vol High
Market backdrop VIX 14.8 · calm Equity put/call 0.58
Technical
price trend
Strong Sell
50 / 200-day cross No cross
Price vs 200-day avg −25%
below
Price vs 50-day avg −9%
below
RSI (14) 34
neutral
MACD trend Negative
52-week position 0%
near low
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Very Weak
1-month return −11%
trailing
6-month return −27%
trailing
YTD return −39%
this year
Relative strength −47%
vs S&P · 6-mo
Sentiment
smart money
Bearish
Trend (MA cross) No cross
50d $110 › 200d $134 — 200d above 50d
Institutional flow Distributing
-8% holders QoQ · +44 funds added
Insider flow Distributing
Net -$100.5K over 90 days · 100% sells
Short interest Rising
8.45% of float · ▲ +11.7% MoM · 5.9 days cover
Volume signal Reversal watch
High volume on a down day — possible exhaustion
Institution breadth Steady
337 holders — mid 3-yr range
Squeeze score 66
elevated · 0–100
Fundamentals
Strong
Revenue growth +1%
Y/Y
Gross margin 25%
expanding
EPS growth +15%
Y/Y
Free cash flow $206.1M
Valuation P/E 14.3
in line
Balance sheet $174.2M
net debt
Quant / Vol
risk profile
High
Volatility 30%
annualized · 1-yr
Max drawdown −45%
past year
ATR 3.4%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Latest guidance · from the Earnings Call filed Aug 25, 2026
fiscal 27
Tax rate Initiated 23%
next year
SG&A growth 10% – 15%
Prior guidance period ended · from the Earnings Call filed Nov 3, 2021
Capital expenditures · fiscal year 2022 $170M – $190M
Effective tax rate · fiscal 2022 24%

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Strong Sell
4 · 3 · 0
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−25% Bearish
Price vs 50-day avg
−9% Bearish
RSI (14)
34 Neutral
MACD trend
Negative Bearish
52-week position
0% Bearish
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Bearish · 3 of 6
Trend (MA cross) No cross
50d $110 › 200d $134 — 200d above 50d
Institutional flow Distributing
-8% holders QoQ · +44 funds added
Insider flow Distributing
Net -$100.5K over 90 days · 100% sells
Short interest Rising
8.45% of float · ▲ +11.7% MoM · 5.9 days cover
Volume signal Reversal watch
High volume on a down day — possible exhaustion
Institution breadth Steady
337 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $100 Now $100 · 0% Range high $181
vs 200-day avg -25% vs 50-day avg -9%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings
Metric Latest Period YoY
GAAP → non-GAAP reconciliation
GAAP Net Sales 1.93B
-20.42M TSA-Related
= Adjusted Consolidated Net Sales 1.91B
GAAP → non-GAAP reconciliation
GAAP Cost of Sales $1.45B
-$20.42M TSA-Related
= Adjusted Cost of Sales $1.43B
GAAP → non-GAAP reconciliation
GAAP Foodservice Net Sales 927.05M
-20.42M TSA-Related
= Adjusted Foodservice Net Sales 906.64M
Adjusted Gross Margin non-GAAP 24.5% Three Months Ended June 30, 2026

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

Packaged Foods — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
MZTI
Marzetti Co
this stock
$2.73B -39.2% +1.1% 14.3 8.4%
JBS
Jbs N.V.
$39.34B -17.1% 1.2%
KHC
Kraft Heinz Co
$28.97B +0.7% -0.1% 8.3%
GIS
General Mills Inc
$19.57B -21.9% +4.1% 8.6%
SJM
J M SMUCKER Co
$13.13B +25.7% +3.7% 4.2%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
337
% held
70.8%
Net QoQ
+1.5M sh
Top holder
BlackRock, Inc.
Held Float
View
Held by Funds
Fund positions
389
View
Short & Settlement
Short Interest Rising
Shares short
2.3M
Days to cover
5.9d
Change
+241.7K sh
View
Short Volume
Short vol %
54%
As of
Sep 21, 2026
Short Total
View
Fails to Deliver
FTD shares
3
Value
$345
As of
Aug 31, 2026
View
Off-Exchange
Off-exchange %
44.1%
Week of
Aug 17, 2026
Off-exch Lit
View
Smart Money
Insider Trades Net selling
Net (90d)
-$100.5K
Buyers / Sellers
0 / 1
Buyers Sellers
View
Financials
Financials
Revenue (FY)
$1.9B
Net income (FY)
$191.6M
EPS diluted
$6.98
View
Buybacks
Authorized
shares 2.0M
Remaining
shares 823.6K
Spent Remaining
View
Filings
SEC Filings
Latest
8-K
Filed
Aug 25, 2026
This year
10
View
Proposed Sales
Value
$100.5K
Shares
997
Filed
Sep 10, 2026
View
Earnings & Events
Earnings Calls Upcoming
Next call
Nov 11, 2026
Last call
Aug 25, 2026
View
Investor Relations
Latest news
The Marzetti Company Reports Four…
Published
Aug 25, 2026
Upcoming events
1
View

Performance

5D 20D 120D MTD YTD
MZTI -4.0% -11.5% -27.1% -11.3% -39.2%
SPY -0.3% -0.1% +20.1% -0.7% +11.7%
vs SPY -3.6% -11.4% -47.3% -10.6% -50.9%

Capital returns

Buyback program · as of Jun 30, 2026
Authorized
shares 2.00M
Spent (derived)
shares 1.18M
Remaining
shares 823,584
Spent Remaining

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 57515 CUSIP 513847103 13F (30d) 10 filings 8 filers Visit website Investor relations